Top FDA drug official is trying to hire a friend who's seeking a bold new warning on antidepressants
The Food and Drug Administration is reviewing a request for new warnings on antidepressant drugs, and that's presenting an unusual conflict of interest at the agency.
While everyone else is frantically filling their weekends with plans to avoid being alone, the most psychologically mature among us are discovering that choosing solitude over Saturday night drinks ...
Amyloid PET has become a pivotal imaging biomarker for Alzheimer disease (AD), enabling in vivo detection and quantification of β-amyloid deposition. However, variability in quantitative measurements ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results